R. W. Evans, D. L. Manninen, L. P. Garrison, and J. , The quality of life of patients with end-stage renal disease, N Engl J Med, vol.312, pp.553-562, 1985.

A. J. Matas, J. M. Smith, and M. A. Skeans, Annual Data Report: kidney, Am J Transplant, vol.15, issue.2, pp.1-34, 2013.

R. A. Wolfe, V. B. Ashby, and E. L. Milford, Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, vol.341, pp.1725-1755, 1999.

S. A. Lodhi, K. E. Lamb, and M. Hu, Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success, Am J Transplant, vol.11, pp.1226-1261, 2011.

J. R. Chapman, What are the key challenges we face in kidney transplantation today?, Transplant Res, vol.2, p.1, 2013.

G. Einecke, B. Sis, and J. Reeve, Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure, Am J Transplant, vol.9, pp.2520-2551, 2009.

J. Sellares, D. G. De-freitas, and M. Mengel, Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am J Transplant, vol.12, pp.388-99, 2012.

C. Roufosse, N. Simmonds, and M. Clahsen-van-groningen, Reference Guide to the Banff Classification of Renal Allograft Pathology Transplantation, vol.11, pp.1795-1814, 2018.

M. Haas, B. Sis, and L. C. Racusen, Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, vol.14, pp.272-83, 2014.

G. Banfi, M. Villa, D. Cresseri, and C. Ponticelli, The clinical impact of chronic transplant glomerulopathy in cyclosporine era, Transplantation, vol.80, pp.1392-1399, 2005.

J. M. Gloor, S. Sethi, and M. D. Stegall, Transplant glomerulopathy: subclinical incidence and association with alloantibody, Am J Transplant, vol.7, pp.2124-2156, 2007.

L. C. Racusen, R. B. Colvin, and K. Solez, Antibody-mediated rejection criteriaan addition to the Banff 97 classification of renal allograft rejection, Am J Transplant, vol.3, pp.708-722, 2003.

L. C. Racusen and M. Haas, Antibody-mediated rejection in renal allografts: lessons from pathology, Clin J Am Soc Nephrol, vol.1, pp.415-435, 2006.

B. Sis, G. S. Jhangri, S. Bunnag, K. Allanach, B. Kaplan et al., Endothelial gene expression in kidney transplants with alloantibody indicates antibodymediated damage despite lack of C4d staining, Am J Transplant, vol.9, pp.2312-2335, 2009.

S. K. Racusenlc and R. B. Colvin, The Banff 97 working classification of renal allograft pathology, Kidney Int, vol.55, pp.713-736, 1999.

K. Solez, R. B. Colvin, and L. C. Racusen, 05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'), Am J Transplant, vol.7, pp.518-544, 2007.

K. Solez, R. B. Colvin, and L. C. Racusen, Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, vol.8, pp.753-60, 2008.

B. Sis, M. Mengel, and M. Haas, 09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups, Am J Transplant, vol.10, pp.464-71, 2010.

M. Mengel, B. Sis, and M. Haas, Meeting report: new concepts in antibody-mediated rejection, Am J Transplant, vol.12, pp.563-70, 2011.

M. Haas, B. Sis, and L. C. Racusen, Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, vol.14, pp.272-83, 2014.

P. F. Halloran, A. Wadgymar, S. Ritchie, J. Falk, K. Solez et al., The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection, Transplantation, vol.49, pp.85-91, 1990.

H. E. Feucht, H. Schneeberger, and G. Hillebrand, Capillary deposition of C4d complement fragment and early renal graft loss, Kidney Int, vol.43, pp.1333-1341, 1993.

C. Lefaucheur, D. Nochy, and D. Glotz,

, Nephrol Ther, vol.4, issue.3, pp.188-91, 2008.

C. Lefaucheur, A. Loupy, and D. Vernerey, Antibody-mediated vascular rejection of kidney allografts: a population-based study, Lancet, vol.381, pp.313-322, 2013.

L. C. Racusen and M. Haas, Antibody-mediated rejection in renal allografts: lessons from pathology, Clin J Am Soc Nephrol, vol.1, pp.415-435, 2006.

J. Kurtkoti, V. Sakhuja, and K. Sud, The utility of 1-and 3-month protocol biopsies on renal allograft function: a randomized controlled study, Am J Transplant, vol.8, issue.2, pp.317-340, 2008.

P. Nickerson, J. Jeffery, and J. Gough, Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection : a pilot study, J Am Soc Nephrol, vol.10, pp.1801-1806, 1999.

R. Mehta, P. Sood, and S. Hariharan, Subclinical Rejection in Renal Transplantation: Reappraised. Transplantation, vol.100, pp.1610-1618, 2016.

O. Kuss, M. Blettner, and J. Börgermann, Propensity Score: an Alternative Method of Analyzing Treatment Effects, World Kidney Day: Chronic Kidney Disease, vol.113, pp.597-603, 2015.

R. W. Evans, D. L. Manninen, L. P. Garrison, and J. , The quality of life of patients with end-stage renal disease, N Engl J Med, vol.312, pp.553-562, 1985.

A. J. Matas, J. M. Smith, and M. A. Skeans, Annual Data Report: kidney, Am J Transplant, vol.15, issue.2, pp.1-34, 2013.

R. A. Wolfe, V. B. Ashby, and E. L. Milford, Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, vol.341, pp.1725-1755, 1999.

S. A. Lodhi, K. E. Lamb, and M. Hu, Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success, Am J Transplant, vol.11, pp.1226-1261, 2011.

J. R. Chapman, What are the key challenges we face in kidney transplantation today?, Transplant Res, vol.2, p.1, 2013.

J. Sellares, D. G. De-freitas, and M. Mengel, Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am J Transplant, vol.12, pp.388-99, 2012.

E. Legendre, H. Thervet, and . Skhiri, Transplantation Journal, vol.65, issue.11, pp.1506-1509, 1998.

B. J. Nankivell, R. J. Borrows, C. L. Fung, P. J. O'connell, and R. D. Allen, , p.249, 2004.

B. J. Nankivell, C. A. Fenton-lee, D. R. Kuypers, E. Cheung, and R. D. Allen,

, Transplantation, vol.71, issue.4, pp.515-523, 1995.

M. S. Kumar, M. Saeed, and K. , Ranganna et al different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: Five-Transplant Immunology, vol.20, pp.32-42, 2008.

B. S. Choi, M. J. Shin, and S. J. , Shin et al protocol biopsy in living-donor renal transplantation: ten-year experience at a 1360, 2005.

B. , , vol.6, 2006.

M. Mengel, J. R. Chapman, and F. G. Cosio,

, American Journal of Transplantation, vol.7, issue.3, pp.512-517, 2007.

T. N. Buchmann, T. Wolff, and A. , Bachmann et al 908 913, Chronic Kidney Disease, vol.17, pp.326-331, 2006.

, 20. protocol biopsy at one month posttransplantation in deceased-donor renal 214, 2007. 21. -term protocol biopsies after kidney 5, Kidne American Journal of Transplantation, vol.11, issue.8, pp.1570-1575, 2011.

K. Solez, R. B. Colvin, and L. C. Racusen, Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, vol.8, pp.753-60, 2008.

D. N. Rush, P. Nickerson, and J. R. Jeffery, Protocol biopsies in renal transplantation: research tool or clinically useful?, Cur Opin Nephrol Hypertens, vol.7, pp.691-694, 1998.

J. Kurtkoti, V. Sakhuja, and K. Sud, The utility of 1-and 3-month protocol biopsies on renal allograft function: a randomized controlled study, Am J Transplant, vol.8, issue.2, pp.317-340, 2008.

A. Schwarz, W. Gwinner, M. Hiss, J. Radermacher, M. Mengel et al., plant protocol of Transplantation, vol.5, issue.8, 2005.

H. E. Wilczek, Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies, Transplantation, vol.50, issue.5, pp.790-797, 1990.

P. N. Furness, C. M. Philpott, and M. T. Chorbadjian, , vol.973, 2003.

T. A. Morgan, S. Burger, and I. M. , Complications of Ultrasound-Guided Renal Transplant Biopsies, Am J Transplant, vol.16, issue.4, pp.1298-305, 2016.

J. M. Gloor, A. J. Cohen, and D. J. Lager, Subclinical rejection intacrolimus-treated renal transplant recipients, Transplantation, vol.73, issue.12, pp.1965-1968, 2002.

F. Moreso, D. Seron, and M. Carrera, Baseline immunosuppression is associated with histological findings in early protocol biopsiesTransplantation, vol.78, pp.1064-10687, 2004.

R. Mehta, P. Sood, and S. Hariharan, Subclinical Rejection in Renal Transplantation: Reappraised. Transplantation, vol.100, pp.1610-1618, 2016.

E. Gotti, N. Perico, and A. Perna, Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings

C. Wehmeier, P. Hirt-minkowski, and P. Amico, Successful steroid withdrawal guided by surveillance biopsies-A single-center experience, Clin Transplant, vol.32, issue.3, p.13181, 2018.

M. C. Haller and M. Kammer, Alexander Kainz Steroids and ciclosporin withdrawal after renal transplantation: a retrospective cohort study, BMC Med, vol.15, p.8, 2017.

F. G. Cosio, M. El-ters, and L. D. Cornell, Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1-Year Protocol Biopsies, Am J Transplant, vol.16, issue.1, pp.194-203, 2016.

P. Simphal1a, . B. Lionet1j, and . Gibier2, Y-a-t-il un intérêt à réaliser une ponction biopsie rénale protocolaire à 3 mois après transplantation rénale, 2018.

K. Nanmoku, A. Kurosawa, and T. Kubo, Effective and Safe Reduction of Conventional Immunosuppressants Using Everolimus in Maintenance Kidney Transplant Recipients, Transplant Proc, vol.49, issue.8, pp.1724-1728, 2017.

D. Wojciechowski, S. Chandran, and F. Vincenti, Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients, Clin Transplant, issue.5, p.31, 2017.

O. Kuss, M. Blettner, and J. Börgermann, Propensity Score: an Alternative Method of Analyzing Treatment Effects, Dtsch Arztebl Int, vol.113, pp.597-603, 2016.

, Supplementary Material SM 1: Graft survival with respect to ci and ct lesions SM 2: Graft survival with respect to cv lesions SM 3: graft survival for the 2009 cohort